Blood and Cancer Institute’s Post

National Cancer Awareness Day Did you know? 🌍 National Cancer Awareness Day was introduced in 2014 by the Government of India to commemorate the birth anniversary of Marie Curie, the pioneering scientist whose work in radioactivity paved the way for advancements in cancer treatment. Her discoveries became the foundation for radiotherapy, offering hope to millions affected by cancer. Today, let’s raise awareness about cancer prevention, early detection, and accessible treatment for all. Early diagnosis can save lives, and knowledge is our most powerful tool against this disease. Let’s pledge to support research, spread awareness, and extend compassion to those affected. 💪❤️ #cancerawareness #Cancer #MarieCurie #CancerAwareness #facts #Radiotherapy #EstevePharma #pharmacy #vitamin #vitaup #emsocool

Gen X Cancer Rates⬆️ Generation X is experiencing larger per-capita increases in the incidence of leading cancers combined than any prior generation born from 1908 through 1964. A study published in JAMA Network Open shows people born between 1965 and 1980 have experienced decreases in certain cancers including lung and cervical. However, several other types of cancer are increasing, including #thyroid, #kidney, #prostate, and #ovarian. This trend of cancer incidence in the US could remain unacceptably high for decades to come. 🔗 A link to the study is in the comments. Source: Rosenberg PS, Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731. PMID: 38857048; PMCID: PMC11165384. #CancerIncidence #GenX

Recent reports indicate a concerning rise in prostate cancer cases globally, with an estimated 14 lakh new cases reported in 2020. Prostate cancer is projected to become even more prevalent by 2040, with an expected increase to 29 lakh cases. It is noted as the most common cancer in men across 112 countries, constituting 15% of all cancer cases. Tragically, an estimated three lakh 75 thousand men succumbed to prostate cancer worldwide in 2020, a number expected to rise by 85% by 2040. Early detection through tests like PSA screening is crucial as prostate cancer typically manifests after the age of 45-50. Prompt diagnosis and appropriate treatment are vital in combating this escalating health challenge. . . . . . #republictalks #news #newsalert #newsupdate #prostatecancer #prostatehealth #prostatecancersurvivor #prostatecancerresearch

🫁 Anyone can get lung cancer. Unfortunately, many people are diagnosed once their disease has already advanced. 🔎 Screening can help detect lung cancer earlier, when treatments are more likely to work. That’s why getting checked is so important for anyone who is at high risk. In Singapore, the SOLSTICE study was set up to examine if Low Dose CT scans and blood-based biomarker tests are effective for lung cancer screening in the local high- and/or at-risk populations. Find out more: https://lnkd.in/dkgRdeeY #LungCancerAwarenessMonth #lungcancer #screening #redefininglungcancertogether

India has achieved a new milestone in cancer treatment. The CD19-directed CAR T-cell therapy, developed by Indian Institute of Technology, Bombay and Tata Memorial Centre, is effective against severe blood cancers like acute lymphoblastic leukemia, non-hodgkin lymphoma, and multiple myeloma. This therapy has successfully completed phase 1 trials, demonstrating safety and efficacy on par with global standards. Supported by the Department of Biotechnology, phase 2 trials are now underway, alongside research into CAR T-cell solutions for other cancers. A proud step towards affordable, indigenous cancer therapies! Read more: https://lnkd.in/dGyUJrFG #BioAngels #CARTCellTherapy #CancerCare #BiotechIndia #Biotechnology

Radio-Chemotherapy Worsens Gut Dysbiosis in Cervical Cancer Patients ksenia klimov, Universidad de Guadalajara, Mexico, presented pioneering research at #TargetingMicrobiota2024 on how radio-chemotherapy exacerbates intestinal dysbiosis in cervical cancer patients from Western Mexico. The study also explored the link between dysbiosis and NK cell exhaustion, highlighting crucial interactions between gut health and immune function in cancer treatment outcomes. #InternationalSocietyofMicrobiota #TargetingMicrobiota2024 #microbiomeresearch #microbiome #microbiota #guthealth #dysbiosis #cancer #cancertreatment

There has been great improvement in #cancer survival rates over time; however, the conclusion below is wrong M. Jamil, Ph.D. The most impact has been from screening, e.g., in #breast and #prostate as well as #cervical cancer - the latter almost eradicated cervical cancer death. Early detected #cancers are treatable today, whereas less than 10% of late-stage cancers have a good outcome. You can read more about the impact of diagnostics on cancer outcomes in Bruce Ratner's book "Early Detection" here is my review of the book and my own 5 cents https://lnkd.in/ecA4MUpE Genomic Expression is raising funds to launch our #RNA diagnostic platform https://lnkd.in/e_jbSKhS?. We have CLIA validated in breast and ovarian cancer with close to 100% diagnostic yield. In contrast, DNA panels yield less than 40% on average, and that drops to half in low mutation frequency tumors. #VC typically doesn't invest in diagnostic, which makes it the least supported tool in the toolbox with the most #Impact. Funding for #biotech was very difficult in general in #2024; early-stage diagnostics, in particular: Cancer diagnostics, which despite their life-saving potential, remain underutilized, underpaid, and therefore underfunded. In 2024, out of the $30B invested in biotech, only $2B went into diagnostics. Of those, only $140M went into four early-stage companies (Series Seed and A, Silicon Valley Bank data). Genomic Expression Inc has unlocked the $560B of philanthropic $$ by passing Realize Impact's rigorous due diligence. They make it simple: fill out the Realize Impact Form here https://lnkd.in/grpHisju and specify your donation "in support of Genomic Expression." Realize Impact made its first investment in Genomic Expression in December. The news will be featured on their website and in a newsletter that will go out to 3,000 impact investors. Kirsten Dinesen Stephanie M. Fowler Pipeline Angels Springboard Enterprises Amy Millman Faz Bashi Nola E. Masterson Trish Costello Joshua Henderson Christina J. Ansted, MPH, CCMEP Greg Simon Eric Topol, MD William A Haseltine Stan Rose Malena Belafonte Constance Williams Mette Dyhrberg Matt Eldridge Katie Couric Stephen Squinto Kevin Conroy

A Hopeful Future for Lung Cancer Treatment 🧬💉 The progress of BNT116 brings hope to lung cancer patients, showcasing the versatility of mRNA technology in targeting various cancers. While clinical trials are essential for advancing medicine, they remain in early stages and require careful study of safety and efficacy. If you're considering a clinical trial, consult your doctor to weigh the potential benefits and risks. This innovative vaccine highlights a promising future for cancer treatment and improved outcomes. More at https://lnkd.in/dnnwqSRZ #CancerResearch #mRNATechnology 🩺🌟 #ClinicalTrials #LungCancerHope #InnovativeMedicine

Advancing Cancer Treatment: Gujarat Cancer Research Institute (GCRI) will soon begin clinical trials for CAR-T cell therapy, a breakthrough in fighting advanced blood cancers. This therapy leverages patients' immune systems and offers hope for many. Read the full story here: https://lnkd.in/dSDB8EbW

Onco Talks by Suchitra Cancer Care Foundation: Episode 2 – Understanding Prostate Cancer with Dr. Akhil Kapoor In this episode of Onco Talks, Dr. Akhil Kapoor, Associate Professor at Tata Memorial Hospital, Varanasi, joins host Gautam Gauri, Co-founder of Suchitra Cancer Care Foundation, to explore prostate cancer in detail. They cover early detection, symptoms, treatment options, and the challenges patients face, particularly in underserved regions like Bihar and eastern UP. Dr. Kapoor shares his expertise on how prostate cancer can be managed and the importance of awareness for early diagnosis. This episode is presented by Suchitra Cancer Care Foundation, as part of their ongoing efforts to raise awareness and provide accurate information about cancer care. Whether you're a patient, caregiver, or simply looking to learn more, this talk offers valuable insights into one of the most common cancers among men. Don't miss out on this informative session! Watch on YouTube- https://lnkd.in/dJmuqGWh #ProstateCancer #OncoTalks #CancerAwareness #DrAkhilKapoor #SuchitraCancerCareFoundation #DikshaFoundation #CancerTreatment #MensHealth